XNETXunlei Ltd

Nasdaq xunlei.com


$ 1.75 $ 0.05 (3.24 %)    

Friday, 17-May-2024 15:40:45 EDT
QQQ $ 451.63 $ -0.22 (-0.05 %)
DIA $ 399.76 $ 0.74 (0.19 %)
SPY $ 529.24 $ 0.76 (0.14 %)
TLT $ 91.40 $ -0.62 (-0.67 %)
GLD $ 223.63 $ 3.63 (1.65 %)
$ 1.75
$ 1.75
$ 0.00 x 0
$ 0.00 x 0
$ 1.71 - $ 1.75
$ 1.28 - $ 2.09
94,281
na
113.23M
$ 1.18
$ 7.96
TBD
na
na ($ 0.00)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
No Data found
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

 xunlei-q1-adj-001-down-from-008-yoy-sales-8036m-down-from-9891m-yoy

Xunlei (NASDAQ:XNET) reported quarterly earnings of $0.01 per share. This is a 83.33 percent decrease over earnings of $0.08 pe...

 xunlei-limited-expects-q1-revenue-of-79m-84m

Guidance for the First Quarter of 2024 For the first quarter of 2024, Xunlei estimates total revenues to be between US$79 mill...

 xunlei-q4-adj-eps-007-up-from-005-yoy-sales-7686m-down-from-9664m-yoy

Xunlei (NASDAQ:XNET) reported quarterly earnings of $0.07 per share. This is a 30.19 percent increase over earnings of $0.05 pe...

 earnings-scheduled-for-march-14-2024

Companies Reporting Before The Bell • Pharming (NASDAQ:PHAR) is projected to report earnings for its fourth quarter.

 earnings-scheduled-for-november-14-2023

Companies Reporting Before The Bell • CureVac (NASDAQ:CVAC) is likely to report quarterly loss at $0.24 per share on revenue o...

 xunlei-q3-adj-eps-008-down-from-013-yoy-sales-8395m-down-from-8807m-yoy

Xunlei (NASDAQ:XNET) reported quarterly adjusted earnings of $0.08 per share. This is a 37.31 percent decrease over earnings of...

 xunlei-q2-adj-eps-013-down-from-014-yoy-sales-10400m-up-from-7802m-yoy

Xunlei (NASDAQ:XNET) reported quarterly adjusted earnings of $0.13 per share. This is a 10.34 percent decrease over earnings of...

 earnings-scheduled-for-august-15-2023

Companies Reporting Before The Bell • Mainz Biomed (NASDAQ:MYNZ) is projected to report earnings for its second quarter.

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION